Cadila Healthcare’s API manufacturing facility located at Ankleshwar (Unit 1) in Gujarat has received an Establishment Inspection Report (EIR). The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 22 to 26, 2019. The EIR report stated that the classification of the facility is ’No Action Indicated (NAI)’
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
